Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK  by Schaeffer, C. et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1643 (2003) 65–73Calcitonin gene-related peptide partly protects cultured smooth
muscle cells from apoptosis induced by an oxidative stress via
activation of ERK1/2 MAPK
C. Schaeffer, D. Vandroux, L. Thomassin, P. Athias, L. Rochette, J.-L. Connat*
Faculte´ des Sciences Gabriel, Laboratoire de Physiopathologie et Pharmacologie Cardiovasculaires Expe´rimentales,
Biologie Animale Cellulaire et Mole´culaire, Universite´ de Bourgogne, IFR Sante´ 100, 6 Bd Gabriel, 21000, Dijon, FranceReceived 18 July 2002; received in revised form 1 September 2003; accepted 23 September 2003Abstract
Oxidative stress induced by a glucose/glucose oxidase (G/GO) generator system dose-dependently decreased the viability of cultured
vascular smooth muscle cells (VSMC) as estimated by MTT assay. Cell death was induced in 40% of cells exposed to 0.2 IU/ml of the free
radical generating mixture. Annexin-V labeling, Hoechst staining together with DNA laddering demonstrated that apoptosis was responsible
for this cell loss. Pretreatment of the cells with 10 8 M calcitonin gene-related peptide (CGRP) significantly attenuated the damaging effect
of the oxidative stress. Indeed, cell viability was estimated to be 80% in CGRP-treated group, instead of 60% in absence of CGRP treatment.
This protective effect of CGRP was antagonized by 8-37 CGRP, an antagonist of CGRP-1 receptors, whereas it was not reproduced by
amylin, a CGRP analogue. As indicated by the reduction in Hoechst staining and in DNA laddering, CGRP prevented the onset of apoptosis.
We also demonstrated that the peptide significantly up-regulated the activation of ERK1/2 and P38 kinases. Inhibitors of the kinases
prevented the protective effect of CGRP. We conclude that CGRP antagonizes oxidative stress-induced apoptosis by up-regulating MAP
kinase activation and that activation of these kinases was necessary to protection.
D 2003 Elsevier B.V. All rights reserved.Keywords: Vascular smooth muscle cell; Apoptosis; Hydrogen peroxide; CGRP; MAPK; SAPK; Neuropeptide1. Introduction
Reactive oxygen species (ROS) are well known to be
toxic in physiopathological contexts. However, ROS can
also act as intracellular signaling agents and play both
physiological and deleterious roles [1,2]. For example,
macrophages produce ROS in cases of organism aggres-
sion in order to eliminate abnormal invading cells. An
oxidative stress is also thought to occur in the early
stages of atherosclerosis [3–6]. In this situation indeed,
vascular smooth muscle cells (VSMC) may be killed by
activated macrophages [7]. It has been recently demon-
strated that macrophages predominantly proliferate in the
middle of the atherosclerotic plaque. The production of
ROS by these cells could induce apoptosis of VSMC,0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2003.09.005
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connatjl@u-bourgogne.fr (J.-L. Connat).leading to a loss of plaque stability and contributing to
the plaque rupture [8–10]. In the particular case of
angioplasty, local inflammation induces the formation of
a plaque containing VSMC, macrophages and vascular
endothelial cells (VEC). VSMC are principally located on
the luminal side and form a fibrous cap that strengthens
plaque. It should be thus hypothesized that protection of
vascular cells from oxidative attack could reduce athero-
sclerosis damage.
Calcitonin gene-related peptide (CGRP) is a 37-amino-
acid neuropeptide characterized by a seven-amino-acid
rings with a disulfide bridge between amino acids 2
and 7. This peptide, featuring a half-life time in mam-
malian plasma of about 10 min, is highly conserved in
various mammalian species and exerts multiple biological
effects on central nervous, gastrointestinal and cardiovas-
cular systems [11,12]. The cardiovascular system is richly
innervated with perivascular CGRP-immunoreactive auto-
nomic nerve fibers. CGRP is known to act as a potent
vasodilator and to exert positive inotropic and chrono-
Fig. 1. Dose effect of GO on VSMC viability as assayed by MTT assay.
VSMC seeded in multiwell plates were treated with GO for 1 h. After 16 h
of re-culture MTT dye was added for 1 h. The reaction was stopped and the
optical density was determined at 570 nm. Results are presented as
percentage of viability/controlF S.D. For each group n= 12.
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reported to modulate the proliferation of VSMC and
VEC. Depending on these cell types, CGRP can exert
either a proliferative or an antiproliferative action [13,14].
In addition, CGRP has been reported to protect myocar-Fig. 2. Morphological analysis of apoptosis. Cells grown on coverslips were treated
staining was realized. Nuclei of control cells appeared with an uniform blue color a
cells were fragmented and intensely stained (arrows, panel 2), typical of condense
double staining was realized. In control cells, neither PI-positive cells nor Annexin
4) were stained with Annexin-V (green) but not with PI (red) confirming that apdial tissue against ischemia–reperfusion injury [15] as
assessed by the reduction of the myocardial enzyme
release [16] and by the diminution in arrhythmias [17].
In this connection, CGRP decreased lipid peroxidation
resulting from ROS release in an animal model of renal
ischemia [18]. Such a protective effect has been also
observed in human [19]. However, these mechanisms
remain very difficult to study in vivo. Moreover, to date,
the possible beneficial effect of CGRP on vascular cells
has not been evaluated.
Therefore, the goal of this study was to investigate in
vitro the cytoprotective role of CGRP on VSMC exposed
to an oxidative stress using a continuous generator system
of H2O2 (glucose/glucose oxidase; G/GO). We estimated
cell viability and apoptosis in stressed cells treated or not
by CGRP. Moreover, the mechanism of transduction of
the signal was studied by determining the membrane
receptor involved and the activation of different MAP
kinases.2. Materials and methods
2.1. Chemicals
Alpha-human-CGRP, Amylin and 8-37 CGRP were
purchased from Bachem, and stored as 20-Al aliquots in
distilled water (1 Ag/Al ) at  20 jC. The inhibitors
PD98059 and SB203580 were purchased from Calbio-or not with GO (0.2 IU/ml) for 1 h. After 16 h of re-culture, Hoechst 33342
nd a regular ovoid shape (panel 1). At the opposite, many nuclei of stressed
d chromatin of apoptotic nuclei. After 5 h of re-culture, Annexin V-FITC/PI
-positive cells were detected (panel 3). At the opposite, stressed cells (panel
optotic process was involved.
Fig. 3. Effect of graded concentrations of CGRP on VSMC viability as
assayed by MTT assay. (A) Control cells that were not submitted to an
oxidative stress. The peptide did not significantly affect viability of cells. For
each group n= 12. (B) Cells that were submitted to an oxidative stress.
Empty bar: control group; dark bars: cells treated with GO 0.2 IU/ml after
exposure to different concentrations of CGRP. For each group n= 6.
***P< 0.001. Results are presented as percentage of viability/controlF S.D.
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mM stock solutions. Annexin V-FITC was purchased
from Molecular Probes. Antibodies for MAP kinases were
obtained from Cell Signalling. Tissue culture materials
were purchased from Falcon Labware. Foetal calf serum
(FCS) was from Seromed. Other products and reagents
used were from Sigma Chemical.
2.2. VSMC isolation and culture
VSMC were obtained from thoracic aortae from 10–12-
week-old Wistar rats. Pieces of the media were carefully
stripped off and incubated in DMEM supplementedwith 10%
FCS. After 1–2 weeks in culture, the VSMC migrate out of
the tissue fragments and begin to proliferate [20]. VSMC
purity was assessed by immunofluorescence staining using
an anti-a-smooth-actin specific antibody (anti-asm1, kindly
supplied by Prof. Gabbiani, University of Geneva, Switzer-
land) and according specific morphological criteria of VSMC
previously described [21]. Cells from passages 5–10 were
used for the present studies. Before use, cells were made
quiescent at 80% confluence by serum deprivation.
2.3. Generation of oxidative stress
The culture medium from cell culture was replaced by
Hank’s balanced salt solution (HBSS) containing 5.5 mM
glucose. The oxidative stress was generated using a con-
centration range of 0.1–0.4 IU/ml glucose oxidase (GO; EC
1.1.3.4, Sigma) for 1 h. For some experiments, after rinsing,
the medium was replaced with DMEM containing 10% FCS
and the cells were used 16 h later.
2.4. Cell treatments
CGRP at a final concentration of 10 8 M was added to
the medium 6 and 3 h before the oxidative stress. The
inhibitors PD98059 and SB203580 were added 1 h before
oxidative stress at the final concentration of 20 and 1 AM,
respectively.
Amylin and the truncated peptide 8-37 CGRP were used
at the final concentration of 10 8 M, like CGRP. When 8-37
CGRP was in combination with CGRP (10 8 M), it was
used at 5 10 8 M.
2.5. Cell viability assay
For the determination of the cell viability, we estimated
bioreduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) [22]. Cells were washed with
PBS and then incubated for 1 h (37 jC; CO2 5%) with MTT
(0.5 mg/ml) in PBS containing CaCl2 (11 mM) and glucose
(5.5 mM). After lysis of the cells in isopropanol–0.1 N HCl,
absorbance was measured at 570 nm. In each experiment,
the assays were performed in 24-well plates and replicates
obtained from 8-well.2.6. Apoptotic cell labeling
Cellswere cultured on coverslips until 80%confluence and
then treated in the samemanner asmentioned above. The cells
were fixed in cold absolute methanol for 2–3 min and then
incubated for 15minwith 10 AMHoechst 33354 compound at
room temperature. After rinsing in PBS, the cells were
mounted in 0.1% Mowiol containing 2.5% DABCO. Cells
with condensed or fragmented nuclei were counted as apo-
ptotic. In each microscopic field a percentage of apoptotic
cells was calculated and averaged over four fields of micro-
scopic observation. In addition, a labeling with Annexin V-
FITC (10AM)andpropidium iodide (PI) (10AM)was realized
on unfixed cells during 10 and 15 min, respectively.
2.7. Analysis of DNA fragmentation
Cells from 10-cm petri dishes were harvested after
trypsinization and pooled with supernatant cells. DNA was
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proteinase K digestion. The extracted DNA (10 Ag) was
loaded on 2% agarose gel containing ethidium bromide and
electrophoresed at 100 V in TBE. The gels were photo-
graphed under UV light.
2.8. Western blotting analysis of MAP kinases
Cells were seeded in six-well plates. All the treatments
were conducted as described above. After rinsing in PBS,
the cells were harvested in lysis buffer (Tris–HCl 50 mM
pH 7.4, NaCl 150 mM, NP40 1%, SDS 1%, PMSF 1 mM,
DTT 1 mM, protease inhibitor cocktail) using a rubber
policeman. Samples were centrifuged (10 000 g, 4 jC)
and the protein concentration was determined using the
Bradford protein assay. After 3 min boiling, protein extract
(40 Ag) was separated by SDS-PAGE on a 10% polyacryl-
amide gel and transferred electrophoretically to nitrocellu-
lose. Nonspecific binding sites were blocked by nonfat milk
powder in TBS–0.1% Tween 20 (TBST). Blots were
incubated with either phosphorylated ERK1/2, phosphory-
lated P38 or phosphorylated JNK antibodies (Cell Signal-
ing) (1/1000). After washing in TBST (3 5 min), the blots
were incubated for 1 h with HRP anti-rabbit antibodies (1/
2000), washed again and observed using ECL system
(Amersham). For each experiment, nitrocellulose sheets
were dehybridized and incubated following the same pro-
cedure with antibodies detecting both phosphorylated and
unphosphorylated forms of MAPK.Fig. 4. Effect of CGRP on GO-induced apoptosis of VSMC. (A) Morphological
oxidative stress. After 16 h of re-culture, number of apoptotic cells was de
condensation. Results are expressed as % of apoptotic cells vs. total number of
Cells were grown in 10-cm petri dishes. After 1-h oxidative stress and 16 h of re
2: cells treated with GO 0.2 IU/ml; Group 3: unstressed cells pretreated with C
DNA marker (200 bp multiples).2.9. Statistical analysis
All results are expressed as meanF S.D. The means were
statistically compared byANOVA, followed by Student t test.
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3.1. Effects of oxidative stress on cultured VSMC
The effects of G/GO were firstly investigated on VSMC
viability, as estimated by MTT assay. A dose-dependent
decrease in cell viability was observed after 1 h of stress and
16 h of re-culture (Fig. 1). At the concentration of 0.2 IU/ml
of GO, the cell viability was diminished by 44%F 2%. In
order to understand the reason of this loss and to discrim-
inate between necrosis and apoptosis, we performed staining
on plated cells. With Hoechst 33342 staining, numerous
nuclei from stressed cells appeared condensed and frag-
mented (Fig. 2.2) while this morphology was never encoun-
tered in control cells (Fig. 2.1). A double staining with
Annexin-V and PI, realized after 5-h re-culture, did not
evidence any positive cells in control cells (Fig. 2.3). At the
opposite, in stressed cells, Annexin V-FITC labeled approx-
imately half of the cell membranes (Fig. 2.4) demonstrating
an externalization of phosphatidyl serine residues typical of
apoptosis. PI failed to stain the nuclei showing the integrity
of the membrane and allowing the exclusion of a necrotic
process.analysis. Cells grown on coverslips were treated with CGRP before a 1-h
termined after staining with Hoechst 33342 on the basis of chromatin
cells. n= 4. ***P< 0.001. (B) DNA fragment analysis on 2% agarose gel.
-culture, DNA was extracted for analysis. Group 1: untreated cells; Group
GRP; Group 4: stressed cells (GO 0.2 IU/ml) pretreated with CGRP; M:
Fig. 5. Specificity of CGRP action. Comparison was realized between the
protective effect of CGRP and those of other peptides. VSMC seeded in
multiwell plates were treated with peptides before oxidative stress and
examined later as in Fig 1. Results are expressed as percentages of viability
vs. controlF S.D. 8-37 corresponds to the truncated 8-37 CGRP, an
antagonist of CGRP1 receptors. See text for concentration used. For each
group n= 6. ***P < 0.001.
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sponds roughly to the IC50, was used for following experi-
ments investigating protective effect of CGRP.
3.2. Protective effect of CGRP treatment
The effects of graded concentrations of CGRP were
evaluated on the cell viability using MTT assay. In
control cells, the peptide did not significantly modify
the viability index at the different concentrations used
(Fig. 3A). After 1 h of stress in the presence of G/GO
and 16 h of re-culture, a significant protective effect
(P < 0.001) on cellular viability was observed when cells
were pretreated with CGRP at 10 7 or 10 8 M (80% in
CGRP-treated cells, respectively, vs. 60% in untreated 
 
Fig. 6. CGRP effect on ERK1/2 activation. Cells were pre-incubated or not (+/
extracted from the cells at the beginning of the stress (0), 30 min (30) and 1 h (60
(60 + 60) the end of the stress period. The immunoblots shown are representative o
whole form of the kinases.stressed cells) (Fig. 3B). The cytoprotective effect of
CGRP was accompanied by a decrease of apoptotic nuclei
number observed after Hoechst staining analysis (Fig.
4A). Moreover, electrophoretical analysis of DNA in the
different experimental conditions showed that DNA frag-
mentation was no more detectable in CGRP-pretreated
culture (Fig. 4B, lane 4 vs. lane 2).
3.3. Assessment of CGRP receptor mediation
In order to determine the involvement of CGRP recep-
tors, treatments with different CGRP analogues were com-
pared in view of their ability to rescue stressed cells from the
oxidative damage. While pretreatment with CGRP signifi-
cantly increased viability (Fig. 5, stack 2, P < 0.001), pre-
treatment with amylin 10 8 M did not (Fig. 5, stack 3). The
truncated peptide 8-37 CGRP, a CGRP receptor antagonist,
also used at a concentration of 10 8 M, failed to reproduce
the CGRP beneficial effects. When 8-37 CGRP was added
in a fivefold excess (5 10 8 M) in combination with
CGRP (10 8 M), the CGRP protective effect was no longer
observed (Fig. 5, stacks 4 and 5).
3.4. CGRP modulation of MAPK transduction signals
The activation of different MAPK involved in stress
response was investigated in VSMC in the absence of
CGRP pretreatment. First, we found that G/GO treatment
induced a dose-dependent activation of ERK1/2. The signal
intensity obtained with 0.2 IU/ml GO was approximately
twice that obtained with 0.1 IU/ml (data not shown).
Therefore, the following experiments were then done with
0.2 IU/ml GO.
The proteins were extracted at different times from
stressed cells pretreated or not with CGRP and immuno-
blotted using antibodies that recognize either the activated
(phosphorylated) form of the kinases or the whole form) with CGRP then stressed or not (+/ ) for 1 h with G/GO. Proteins were
) after the beginning of the stress and then 30 min (60 + 30) and 1.0 h after
f three independent experiments. Top: activated form of the kinases; bottom:
 Fig. 7. CGRP effect on P38 activation. Western blot analysis. Cells were pre-incubated or not (+/ ) with CGRP then stressed or not (+/ ) for 1 h with G/GO.
Proteins were extracted from the cells at the beginning of the stress (0), 30 min ( 30) and 1 h (60) after the beginning of the stress and then 30 min (60 + 30) and
1.0 h after (60 + 60) the end of the stress period. The immunoblots shown are representative of three independent experiments. Top: activated form of the
kinases; bottom: whole form of the kinases.
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ning of the stress, a small content of phosphorylated ERK1/
2 (Phospho-ERK1/2) was detected in stressed cells. CGRP
pretreatment greatly increased the signal, especially at the
Phospho-ERK2 level (p42). This up-regulation of ERK was
only observed at this moment and not later (Fig. 6). The
whole form of ERK1/2 was found to be constant at each
time investigated.
Similar experiments were conducted with anti P38 anti-
bodies. No phosphorylated (activated) form of this kinase
was found during oxidative stress. Moreover, the wholeFig. 8. Effect of kinases inhibitors PD98059 and SB 203580 on CGRP-
induced cell protection. VSMC seeded in multiwell plates were treated with
CGRP and MAP kinases inhibitors before oxidative stress and examined
later (see Section 2). Cell viability was evaluated using MTT assay. Results
are expressed as percentages of viability vs. controlF S.D. For each group
n= 6. ***P < 0.001; **P < 0.01.form of this kinase was constant. The phosphorylated P38
kinase (Phospho-P38) was found 30 min and 1 h after the
end of oxidative stress in untreated cells (Fig. 7). Signal
intensity found in CGRP-pretreated cells was increased 30
min after the oxidative stress.
Finally, immunoblots were done in the same conditions
with antibodies against JNK. The activated form of JNK
(phosphorylated) was never observed, although the blots
contained the inactive form of the kinase visualized by the
pan-antibody (data not shown).
3.5. ERK1/2 and P38 inhibitors suppress the beneficial
effect of CGRP
In this experiment, cells were pre-incubated with differ-
ent MAP kinase inhibitors as explained in Section 2. Cell
viability was estimated using MTT 16 h after the oxidative
stress. PD98059, a specific inhibitor of ERK1/2, clearly
inhibited the rescue in cell viability induced by CGRP
(P < 0.001). The effect of P38 inhibitor (SB203580) was
less pronounced but remained significant (P < 0.01). The
combination of both inhibitors gave similar results (Fig. 8).4. Discussion
Oxidative stress is well recognized as an important trigger
in the complex chain of events leading to atherosclerosis.
‘‘Reactive oxygen species have also been implicated in the
pathophysiology of restenosis after percutaneous coronary
interventions (PCI)’’ [23]. Taking into account a possible role
of CGRP in protecting VSMC against stress-associated
diseases, the purpose of this study was to estimate the effect
of pretreating VSMC by CGRP on survival of cells exposed
to an oxidative stress. G/GO was used as an enzymatic
generator of extracellular H2O2. As previously published
[24], we confirmed that H2O2 caused a decrease in VSMC
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apoptotic process. This was shown by DNA laddering,
presence of condensed apoptotic nuclei (Hoechst staining)
and Annexin-V labeling. Moreover, we have unveiled a close
relationship between the number of apoptotic nuclei and the
index of viability obtained by MTT assay.
We demonstrate here that cell death following the oxi-
dative stress was significantly lower when the cells were
pretreated twice with 10 8 M CGRP. In these experimental
conditions, approximately half of the cells in which apo-
ptosis was induced by G/GO were preserved. The number of
Hoechst-stained apoptotic nuclei was diminished and the
DNA laddering was no more detectable, showing a potent
effect of CGRP in preventing apoptosis. Moreover, we
checked that this effect of CGRP was independent on the
modulatory role of CGRP on the VSMC proliferation, since
in our conditions neither cytotoxic nor proliferative effects
of CGRP were observed. This observation is relevant, since
this peptide (as other belonging to the same family [25] is
involved in the control of VSMC proliferation and can
either increase or diminish VSMC proliferation, as previ-
ously described [13].
The MAPK superfamily, composed of the extracellular
signal regulated kinases (ERKs) and the stress activated
kinases (SAPK, also referred as the c-Jun N-terminal
kinases (JNKs = SAPK1), and the P38 kinases = SAPK2/
3), is implicated in cell proliferation, cell death and cell
survival [26]. It has been previously demonstrated that
ERK1/2 pathway is involved in the inactivation of the
pro-apoptotic protein Bad by phosphorylation [27] and
plays a positive role in cell survival following oxidant
injury [28–30]. In the present study we confirmed the effect
of ROS on ERK1/2 activation. In addition, we demonstrated
that CGRP pretreatment up-regulates activation of these
kinases (mostly ERK2) during the oxidative stress period.
The protective effect of CGRP is abolished when ERK1/2 is
inhibited, indicating that up-regulation of ERK1/2 protects
cell from death induced by oxidative stress. P38 has also
been reported to be induced during oxidative stress [31,32].
Its activation causes phosphorylation of HSP27, which may
also be important in cardioprotection. In our model, P38 is
activated only after the end of the oxidative stress. We
observed that CGRP temporarily and slightly up-regulates
the activity of this enzyme. Since CGRP protective effect
was abolished when either ERK1/2 or P38 was inhibited, it
appears that both kinases are implicated in the inhibition of
apoptosis.
It could be thus hypothesized that an oxidative stress
normally activates stress kinases to protect the cells. The
pretreatment with CGRP potentiated this activation and
induced a better protection of the cells resulting in a
decrease in the apoptotic process. This could be not the
only pathway by which the protection is exerted. Shichiri et
al. 1999 [25] demonstrated that both CGRP and adrenome-
dullin (ADM) induced the expression of Max, a heterodi-
meric partner of c-Myc, which may contribute to rescueendothelial cells from apoptosis. More recently, ADM was
shown to lower apoptotic death of rat thymocytes [33].
In our results, CGRP did not protect all cells against
death (80%). This could be due either to the fact that the
CGRP used is human CGRP and not the slightly different
isoform found in rat or because the involved receptor is not
totally specific for CGRP. Recently, MacLatchie et al. [34]
demonstrated that a family of proteins called receptor-
activity-modifying proteins (RAMPs) was able to combine
calcitonin-receptor-like receptor (CRLR) and to traffic it to
the plasma membrane. The nature of the RAMP expressed
specifies the affinity for the different ligands. For example,
RAMP1 confers specificity for CGRP while expression of
RAMP2 and RAMP3 defines ADM receptors. The com-
pound 8-37 CGRP that we used in this study abolished the
protective effect of CGRP pretreatment. This compound is
an antagonist of CGRP receptors that is also able to bind
with high-affinity functional ADM receptors expressed on
rat VSMC [35]. At the opposite CGRP analogues, such as
amylin, did not produce similar effects. This indicates that
the protective effect of CGRP observed in this study is
mediated via a specific receptor for CGRP and/or ADM.
Numerous CGRP nerve terminals exist in blood vessels
[36] and the results presented here show that CGRP can
prevent oxidative-stress-induced apoptosis in VSMC. In
atherosclerosis process, the development of the plaque is
due, in part, to macrophages infiltration. These inflamma-
tory cells produce ROS, which exert proapoptotic action on
VSMC [24] and destabilize the fibrous cap leading to plaque
rupture [37]. Thereby, CGRP could have a beneficial effect
by preventing plaque rupture by acting on MAP kinase
activation. A beneficial effect of CGRP in case of cardiac
ischemia/reperfusion due to an inhibition of TNFa produc-
tion has been also reported [38]. All these data could
probably be extended to many pathophysiological states or
diseases, like aging and diabetes, in which vascular oxidant
stress appears to be increased [39] and vascular CGRP
diminished [40,41]. In conclusion, a neuropeptide such as
CGRP can prevent VSMC apoptosis induced by oxidative
stress through the activation of MAP kinases which are
implicated in proliferation and apoptosis pathways. This
protective effect appeared to involve CGRP binding to a
receptor. Further studies seem to be required to seek for
other possible beneficial actions of CGRP on other apopto-
sis induction processes and to determine the signaling
pathway linking CGRP to MAP kinase induction. These
informations unveil an unknown role of CGRP, which could
be of interest in the context of protection against cardiovas-
cular diseases, particularly those involving free radical
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